Skip to main content
. 2015 May 14;21(18):5685–5694. doi: 10.3748/wjg.v21.i18.5685

Figure 1.

Figure 1

Effect of oral administration of AlequelTM on clinical remission. Percent of subjects in clinical remission (Crohn’s disease activity index < 150) during the course of the study. Black bars represent the AlequelTM-treated group and open bars represent the placebo group. The evaluable number of patients in each group was too small to reach a statistical significance.